GlassScriptPhysician profile
Omar S Jalil
NPI 1083727424
$1,446.66
in general payments reported to CMS, 2019-2025
15 companies · $134 in 2025
The $134 reported for 2025 was less than what a typical Internal Medicine provider received nationally (typical 2025 total: $156).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $396 · 2020: $189 · 2021: $120 · 2022: $145 · 2023: $62.21 · 2024: $401 · 2025: $134.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $597.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $597.07 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Kerecis Limited | $403.64 | 2023-2025 | Kerecis Omega3 Marigen, Kerecis Surgiclose, Kerecis Omega3 Surgiclose |
| Smith+Nephew, INC. | $194.57 | 2020-2024 | Pico 14, Renasys Go V2 Home, Grafix Pl |
| Janssen Pharmaceuticals, INC | $181.11 | 2019 | |
| Salix Pharmaceuticals, A Division of Bausch Health US, LLC | $155.40 | 2019-2020 | |
| Aroa Biosurgery Incorporated | $122.20 | 2022 | |
| Hydrofera LLC | $102.76 | 2024 | Hydrofera Blue |
| Ethicon US, LLC | $101.49 | 2020 | |
| Organogenesis INC. | $35.03 | 2021-2024 | |
| Novartis Pharmaceuticals Corporation | $34.85 | 2019 | |
| Integra Lifesciences Corporation | $28.52 | 2020 | |
| Astrazeneca Pharmaceuticals LP | $21.74 | 2019 | |
| Ets Wound Care LLC | $19.07 | 2025 | Mirragen Advanced Wound Matrix |
| Boston Scientific Corporation | $18.48 | 2020 | |
| Abbott Laboratories | $16.14 | 2019 | |
| E.R. Squibb & Sons, L.L.C. | $11.66 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Omar Jalil listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.